Litcius/Paper detail

Low-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Trial

Michael Chu, Marc Ruel, Allen Graeve, Marc Gerdisch, Ralph J. Damiano, Robert L. Smith, W. Brent Keeling, Michael A. Wait, Robert Hagberg, Reed D. Quinn, Gulshan K. Sethi, Rosario Floridia, Christopher J. Barreiro, Andrew L. Pruitt, Kevin Accola, François Dagenais, Alan Markowitz, Jian Ye, Michael Sekela, Ryan Tsuda, David A Duncan, Daniel G. Swistel, Lacy E. Harville, Joseph J. DeRose, Eric J. Lehr, John H. Alexander, John D. Puskas, Jian Ye, Chun “Dan” Choi, Gösta Pettersson, Marc Gerdisch, O.H. Frazier, Jeffrey Askew, Ralph J. Damiano, Andrew L. Pruitt, David Duncan, Romualdo J. Segurola, Mohammad Shoukfeh, Igor D. Gregorič, Steven Meyer, Michael Chu, Danny Chu, Robert Hagberg, Rosario Floridia, Ryan Tsuda, Eric Kirker, Daniel G. Swistel, W. Brent Keeling, Lance Landvater, Christopher J. Barreiro, Brian Castlemain, Peter Tutuska, Reed D. Quinn, Thomas M. Beaver, Kevin Accola, Gulshan K. Sethi, Alan Graeve, David Liu, Michael A. Wait, Bryan A. Whitson, Lacy Harville, Joseph J. DeRose, Eric J. Lehr, François Dagenais, Alan Markowitz, Michael Sekela, Robert L. Smith, Christian Shults, Prem Shekar, Vinay Badhwar

2023The Annals of Thoracic Surgery38 citationsDOIOpen Access PDF

Topics & Concepts

MedicineWarfarinClinical endpointRandomized controlled trialMitral valve replacementSurgeryAspirinThrombosisMitral valveCardiologyInternal medicineAtrial fibrillationCardiac Valve Diseases and TreatmentsAtrial Fibrillation Management and OutcomesMechanical Circulatory Support Devices